Physician

Mark Bevan, M.D.

According to 2025 Medicare claims, Mark Bevan, M.D. (NPI: 1720185788) practices nephrology in the Farmington, NM market, with the plurality of this provider's patient population coming from San Juan, NM. This provider's primary affiliated billing organization is FOUR CORNERS NEPHROLOGY ASSOCIATES PC (NPI: 1144327172; TIN: 85-0376888) and primary practice location at 87401-6589.

Bevan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 556 traditional Medicare patients, billed 18,973 HCPCS/CPT codes, and received $995,713 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 3,003 prescription claims across 277 beneficiaries totaling $262,040 in drug costs, led by Lokelma (Sodium Zirconium Cyclosilicate). 2023 DME data shows 13 claims. Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $683,292 to $262,040. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,311 to $2,259.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	926	16,698	$1,315,778
2016	875	15,967	$1,328,459
2017	809	17,419	$1,261,360
2018	849	17,900	$1,332,811
2019	852	18,640	$1,386,086
2020	805	20,281	$1,352,069
2021	767	16,060	$1,424,795
2022	685	14,010	$1,160,507
2023	564	18,560	$950,223
2024	556	18,973	$995,713

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	401	5,432	$683,292
2016	417	5,288	$764,925
2017	405	4,748	$718,691
2018	403	4,410	$455,824
2019	415	5,071	$431,845
2020	406	4,900	$362,046
2021	363	4,496	$414,737
2022	335	4,110	$398,297
2023	323	3,698	$349,550
2024	277	3,003	$262,040

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	82	$3,018
2016	N/R	76	$2,591
2017	N/R	54	$4,661
2018	N/R	151	$7,147
2019	N/R	208	$8,127
2020	N/R	166	$8,096
2021	N/R	220	$10,207
2022	N/R	24	$1,399
2023	N/R	13	$163
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	344	2,220	$293
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	230	591	$243
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	43	68	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	78	97	$72
90970	Dialysis services, per day, less than full month service (20 years or older)	312	15,443	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lokelma	Sodium Zirconium Cyclosilicate	55	1,798	$58,516
Velphoro	Sucroferric Oxyhydroxide	19	555	$56,530
Sevelamer Carbonate	Sevelamer Carbonate	155	5,044	$29,018
Renvela	Sevelamer Carbonate	16	476	$25,423
Calcium Acetate	Calcium Acetate	281	9,524	$18,714

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$14	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Bevan, M.D.?

Tedicare shows public-source Medicare data for Mark Bevan, M.D. (NPI 1720185788), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Bevan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Bevan, M.D.?

Mark Bevan, M.D. is linked to FOUR CORNERS NEPHROLOGY ASSOCIATES PC (billing NPI 1144327172) in the available physician profile data.

Does Mark Bevan, M.D. have Open Payments data?

Mark Bevan, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.